We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+385.76%
AUM
$455B
AUM Growth
-$1.21B
Cap. Flow
+$3.82B
Cap. Flow %
0.84%
Top 10 Hldgs %
15.66%
Holding
8,005
New
478
Increased
3,039
Reduced
3,074
Closed
321

Sector Composition

Rank Sector Weight
1 Technology 15.75%
2 Healthcare 8.81%
3 Financials 8.45%
4 Consumer Discretionary 7.56%
5 Industrials 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRV icon
6301
AmeriServ Financial
ASRV
$83.5M
$2K ﹤0.01%
558
-4
-0.7% -$15
ATOM icon
6302
Atomera
ATOM
$214M
$2K ﹤0.01%
100
-200
-67% -$4.34K
AVTX icon
6303
Avalo Therapeutics
AVTX
$983M
-6
Closed -$48.6K
BASE
6304
DELISTED
Couchbase
BASE
$2K ﹤0.01%
+68
New +$2.5K
BH.A icon
6305
Biglari Holdings Class A
BH.A
$1.21B
$2K ﹤0.01%
3
BHR
6306
Braemar Hotels & Resorts
BHR
$142M
$2K ﹤0.01%
354
-942
-73% -$4.92K
BLFY
6307
DELISTED
Blue Foundry Bancorp
BLFY
$2K ﹤0.01%
+146
New +$1.96K
BLRX
6308
BioLineRX
BLRX
$11.8M
$2K ﹤0.01%
18
CANF
6309
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$2K ﹤0.01%
8
CENN icon
6310
Cenntro
CENN
$8.43M
0
CLSD
6311
DELISTED
Clearside Biomedical
CLSD
$2K ﹤0.01%
24
-1
-4% -$88
CLX icon
6312
PUT
Clorox
CLX
$12.7B
$2K ﹤0.01%
11
CNVS icon
6313
Cineverse
CNVS
$65.6M
$2K ﹤0.01%
42
+13
+45% +$458
CSAN icon
6314
Cosan
CSAN
$2.84B
$2K ﹤0.01%
119
-130
-52% -$2.38K
CTKB icon
6315
Cytek Biosciences
CTKB
$546M
$2K ﹤0.01%
+81
New +$1.91K
DFH icon
6316
Dream Finders Homes
DFH
$1.36B
$2K ﹤0.01%
111
-10,853
-99% -$226K
DJCO icon
6317
Daily Journal
DJCO
$778M
$2K ﹤0.01%
5
-9
-64% -$2.95K
ELTX icon
6318
Elicio Therapeutics
ELTX
$83.8M
$2K ﹤0.01%
18
+8
+80% +$864
ENVB icon
6319
Enveric Biosciences
ENVB
$6.24M
-1
Closed -$19.4K
EPM icon
6320
Evolution Petroleum
EPM
$131M
$2K ﹤0.01%
436
-13
-3% -$58
EPOL icon
6321
iShares MSCI Poland ETF
EPOL
$756M
$2K ﹤0.01%
92
-323
-78% -$7.14K
ERAS icon
6322
Erasca
ERAS
$6.39B
$2K ﹤0.01%
+114
New +$2.35K
FATBB
6323
DELISTED
FAT Brands
FATBB
$2K ﹤0.01%
+396
New +$2.69K
FDNI icon
6324
First Trust Dow Jones International Internet ETF
FDNI
$32.3M
$2K ﹤0.01%
60
FSTR icon
6325
Foster
FSTR
$432M
$2K ﹤0.01%
106
-3
-3% -$51

Similar funds

Wells Fargo's Q3 2021 Portfolio in Review

As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
  • Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
  • Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
  • Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
  • Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
  • Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
  • Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.

Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.